RIGEL KENT SECURITY AND ADVISORY SERVICBusiness Directories,Company Directories

Company Name: Corporate Name:	RIGEL KENT SECURITY AND ADVISORY SERVIC
Company Title:
Company Description:
Keywords to Search:
Company Address:	180 Preston St,OTTAWA,ON,Canada
ZIP Code: Postal Code:	K1R
Telephone Number:	6132334225
Fax Number:
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):	59440
USA SIC Description:	COMPUTERS SECURITY SVCS
Number of Employees:
Sales Amount:	Less than $500,000
Credit History: Credit Report:	Unknown
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
RIGHT INVENTIONS INC
RIGHT FORMING LIMITED
RIGHT FORMING LTD

Next company profile:
RIEGER PRINTING INK
RIEGER PRINTING INK
RIDOUT & MAYBEE

Company News:

Rigel Pharmaceuticals, Inc. (RIGL)
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer
Pipeline :: Rigel Pharmaceuticals, Inc. (RIGL)
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases
Investor Relations :: Rigel Pharmaceuticals, Inc. (RIGL)
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel, small molecule drugs that significantly improve the lives of patients with immune and hematological disorders, cancer and rare diseases
Products :: Rigel Pharmaceuticals, Inc. (RIGL)
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases
Management Team :: Rigel Pharmaceuticals, Inc. (RIGL)
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases
Join Our Team :: Rigel Pharmaceuticals, Inc. (RIGL)
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases
Rigel Reports First Quarter 2025 Financial Results and Provides . . .
Rigel continues to advance its Phase 1b clinical study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of R289 in patients with relapsed or refractory (R R) lower-risk MDS
SEC Filings :: Rigel Pharmaceuticals, Inc. (RIGL)
© 2025 Rigel Pharmaceuticals, Inc All Rights Reserved TAVALISSE, TAVLESSE, REZLIDHIA, GAVRETO, RIGEL and the Rigel arc logo are registered trademarks of Rigel Pharmaceuticals, Inc
Press Releases :: Rigel Pharmaceuticals, Inc. (RIGL)
Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R R mIDH1 AML in the Journal of Hematology Oncology Nov 12, 2025 8:05am EST
Clinical Trials :: Rigel Pharmaceuticals, Inc. (RIGL)
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases